期刊文献+

帕米膦酸二钠合复方苦参注射液治疗恶性肿瘤骨转移致疼痛 被引量:4

下载PDF
导出
摘要 目的:分析帕米膦酸二钠联合复方苦参注射液治疗恶性肿瘤骨转移所致疼痛的临床价值。方法:选取我院2015年6月~2017年7月收治的恶性肿瘤骨转移所致疼痛79例患者为研究对象,根据治疗方式不同分为研究组40例与参照组39例。参照组使用帕米膦酸二钠治疗,研究组在参照组基础上,予复方苦参注射液治疗,比较两组治疗后疼痛缓解情况、生存质量、不良反应发生情况及治疗前后ALP指标。结果:治疗后,研究组疼痛缓解率明显高于参照组,P<0.05;研究组生存质量稳定率明显高于参照组,P<0.05;研究组不良反应发生率明显低于参照组,P<0.05;研究组ALP水平明显低于参照组,P<0.05。结论:帕米膦酸二钠与复方苦参注射液联合用于恶性肿瘤骨转移中效果理想,可减轻患者疼痛,减少不良反应,提升生存质量,值得临床应用。
作者 李伟芳
出处 《实用中西医结合临床》 2019年第2期43-45,共3页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献9

二级参考文献59

  • 1吴迪,梁健,廉建伟,张蕾,陈晓辉,毕开顺.RP-HPLC法同时测定复方苦参注射液中氧化槐果碱、氧化苦参碱和苦参碱的含量[J].沈阳药科大学学报,2006,23(4):220-223. 被引量:47
  • 2Bickels J,Dadia S,Lidar Z.Surgical management of metastatic bone disease[J].J Bone Joint Surg Am,2009,91(6):1503-1516.
  • 3Van Seventer R,Smit JM,Schipper RM,et a1.Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain[J].Curr Med Res Opin,2003,19(6):457-659.
  • 4Marier JF,Lor M,Morin J,et al.Comarative bioequivlaence study between a novel matrix transdermal delivery system of fentanyl and a commercially available reservoir formulation[J].Br J Clin Pharmacol,2007,63(1):121-124.
  • 5Marier JF,Lor M,Potivn D,et al.Pharmacokinetics,tolerability,and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects[J].J Clinical Pharmacology,2006,46(6):642-653.
  • 6Croucher P,Jagdev S,Coleman R.The anti-tumor potential of zoledronic acid[J].Breast Cancer,2003,12(2):30-36.
  • 7Welligton K,Goa KL.Zoledronic acid:a review of its use in the management of bone metastases and hypercalcaemis of malignancy[J].Durgs,2003,63(4):417-437.
  • 8Weinfurt KP,Castel LD,Li Y,et a1.Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions[J].Med Care,2004,42(2):164-175.
  • 9Kunzmann V,Bauer E,Feurle J,et al.Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma[J].Blood,2000,96(2):384-392.
  • 10Hillner BE, Ingle JN, Berenson JR, et al. American Society of Clini-cal Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Ex- pert Panel [ J ]. J Clin Onco1,2000,18 (6) : 1378 - 1391.

共引文献60

同被引文献84

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部